Johns Hopkins Diabetes Guide
Phentermine
INDICATIONS
FDA
FDA
- Adult and pediatric patients older than 16 years of age for short-term management of obesity (adjunct to weight reduction program of exercise, behavioral modification and caloric restriction) in patients with an initial BMI ≥ 30 kg/m2, or BMI ≥ 27 kg/m2 in the presence of other risk factors (e.g., hypertension, diabetes, hyperlipidemia).
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: February 2, 2022
Citation
Béliard Veillard, Régine, et al. "Phentermine." Johns Hopkins Diabetes Guide, The Johns Hopkins University, 2022. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547120/9/Phentermine.
Béliard Veillard , Lee C, Dalpoas SE, Alavi R. Phentermine. Johns Hopkins Diabetes Guide. The Johns Hopkins University; 2022. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547120/9/Phentermine. Accessed October 8, 2025.
Béliard Veillard, ., Lee, C., Dalpoas, S. E., & Alavi, R. (2022). Phentermine. In Johns Hopkins Diabetes Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547120/9/Phentermine
Béliard Veillard , Lee C, Dalpoas SE, Alavi R. Phentermine [Internet]. In: Johns Hopkins Diabetes Guide. The Johns Hopkins University; 2022. [cited 2025 October 08]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547120/9/Phentermine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Phentermine
ID - 547120
A1 - Béliard Veillard, Régine,PharmD, BCACP, TTS
AU - Lee,Clare,M.D., MHS
AU - Dalpoas,Stacy,Pharm.D., BCP
AU - Alavi,Reza,M.D.
Y1 - 2022/02/02/
BT - Johns Hopkins Diabetes Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547120/9/Phentermine
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
